 |
|
|
| Iron Metabolism and Anemia |
| Date: | Sunday, 15 June 2003 |
| Time: | 11:30-12:45 |
| Room: | Room III (ENS building) |
| 11:30-11:45 |
0907 |
|
|
PHARMACOKINETIC AND MODE-OF-ACTION STUDIES OF CERA (CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR), A NOVEL ERYTHROPOIETIC AGENT WITH AN EXTENDED SERUM HALF-LIFE
A. Haselbeck, P. Reigner, P. Jordan, A. Pannier (Penzberg, Germany)
| 11:45-12:00 |
0908 |
|
|
CARDIAC DISEASE IN WELL-TREATED PATIENTS WITH THALASSEMIA MAJOR
D. Farmakis, C. Fragodimitri, F. Karabatsos, J. Youssef, A. Hatziliami, S. Deftereos, E. Mitilineou, M. Karagiorga, A. Aessopos (Athens, Greece)
| 12:00-12:15 |
0909 |
|
|
PHARMACOKINETICS (PK) PROFILE OF THE NEW ORAL IRON CHELATOR ICL670 AFTER 6 MONTHS OF TREATMENT IN A PHASE II STUDY IN PATIENTS WITH TRANSFUSIONAL HEMOSIDEROSIS
M.D. Cappellini, R. Galanello, A. Piga, G.L. Forni, H. Opitz, J.M. Ford, R. Sechaud, C. Mueller, D. Alberti (Milano, Italy)
| 12:15-12:30 |
0910 |
|
|
MRI IN THE EVALUATION OF IRON OVERLOAD IN PATIENTS WITH THALASSEMIA MAJOR AND SICKLE CELL SYNDROMES
E.V. Voskaridou, M.D. Douskou, I.S. Seimenis, P.B. Baras, D.S. Skoutas, H.P. Plata, Y.P. Papasotiriou, A.S. Stamoylakatou, A.L. Loutradi, A.O. Ourailidis, D.L. Loukopoulos (Athens, Greece)
| 12:30-12:45 |
0911 |
|
|
MAPPIT-BASED INTERACTION MAPPING OF THE INTRACELLULAR PART OF THE ERYTHROPOIETIN RECEPTOR
T.R. Montoye, S. Eyckerman, A. Verhee, J. Van der Heyden, I. Lemmens, J. Tavernier (Ghent, Belgium)
|